The comparative effectiveness of natalizumab and ocrelizumab in naive relapsing remitting multiple sclerosis: the impact on relapse dependent and relapse independent disability progressionPietro Iaffaldano, Giuseppe Lucisano,Tommaso Guerra,Damiano Paolicelli,Matilde Inglese,Matteo Foschi,Francesco Patti,Franco Granella,Silvia Romano,Paola Cavalla,Giovanna De Luca,Paolo Gallo,Paolo Bellantonio,Antonio Gallo,Sara Montepietra,Alessia Di Sapio,Marika Vianello, Rocco Quatrale,Daniele Spitaleri,Raffaella Clerici,Valentina Torri Clerici,Eleonora Cocco,Vincenzo Brescia Morra,Girolama Alessandra Marfia,Massimo Filippi,Maria Pia Amato,Maria TrojanoMULTIPLE SCLEROSIS JOURNAL（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
